Transfusion support for veteran patients

Alex Ryder, Christopher A. Tormey

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The transfusion of blood products is an important and often life-saving aspect of medical management for military veterans seeking care at Veterans Administration (VA) facilities. However, blood product infusion is a complex process that is associated with both infectious and non-infectious hazards. Thus, the aim of this chapter is to review transfusion therapy for veteran patients with a particular emphasis on those guidelines and risks most applicable to veteran populations. The authors will outline current, evidence-based approaches for transfusions of red blood cells, platelets, plasma, and cryoprecipitate and discuss how these relate to veteran groups. Moreover, the authors will share their practical experiences in transfusion management at a large, VA Healthcare System especially for areas of management (e.g. the use of factor concentrates for non-hemophilia patients) which currently lack discrete, evidence-based approaches. Finally, the authors will address the risks of transfusion with a focus on those aspects of transfusion hazards that have been well-studied and are particularly unique to veteran patients (e.g. RBC alloimmunization and delayed hemolytic transfusion reactions). Practical strategies to overcome these potential problems will also be reviewed.

Original languageEnglish (US)
Title of host publicationVeterans
Subtitle of host publicationHealth Issues, Coping Strategies and Benefits
PublisherNova Science Publishers, Inc.
Pages1-26
Number of pages26
ISBN (Print)9781620812686
StatePublished - Mar 1 2012

Fingerprint

Veterans
United States Department of Veterans Affairs
management
evidence
Military
Plasma Cells
Blood Transfusion
lack
Blood Platelets
Guidelines
experience
Delivery of Health Care
Group
Population

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Social Sciences(all)

Cite this

Ryder, A., & Tormey, C. A. (2012). Transfusion support for veteran patients. In Veterans: Health Issues, Coping Strategies and Benefits (pp. 1-26). Nova Science Publishers, Inc..

Transfusion support for veteran patients. / Ryder, Alex; Tormey, Christopher A.

Veterans: Health Issues, Coping Strategies and Benefits. Nova Science Publishers, Inc., 2012. p. 1-26.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ryder, A & Tormey, CA 2012, Transfusion support for veteran patients. in Veterans: Health Issues, Coping Strategies and Benefits. Nova Science Publishers, Inc., pp. 1-26.
Ryder A, Tormey CA. Transfusion support for veteran patients. In Veterans: Health Issues, Coping Strategies and Benefits. Nova Science Publishers, Inc. 2012. p. 1-26
Ryder, Alex ; Tormey, Christopher A. / Transfusion support for veteran patients. Veterans: Health Issues, Coping Strategies and Benefits. Nova Science Publishers, Inc., 2012. pp. 1-26
@inbook{b5cede32e35b435c8962dcf4db5ea417,
title = "Transfusion support for veteran patients",
abstract = "The transfusion of blood products is an important and often life-saving aspect of medical management for military veterans seeking care at Veterans Administration (VA) facilities. However, blood product infusion is a complex process that is associated with both infectious and non-infectious hazards. Thus, the aim of this chapter is to review transfusion therapy for veteran patients with a particular emphasis on those guidelines and risks most applicable to veteran populations. The authors will outline current, evidence-based approaches for transfusions of red blood cells, platelets, plasma, and cryoprecipitate and discuss how these relate to veteran groups. Moreover, the authors will share their practical experiences in transfusion management at a large, VA Healthcare System especially for areas of management (e.g. the use of factor concentrates for non-hemophilia patients) which currently lack discrete, evidence-based approaches. Finally, the authors will address the risks of transfusion with a focus on those aspects of transfusion hazards that have been well-studied and are particularly unique to veteran patients (e.g. RBC alloimmunization and delayed hemolytic transfusion reactions). Practical strategies to overcome these potential problems will also be reviewed.",
author = "Alex Ryder and Tormey, {Christopher A.}",
year = "2012",
month = "3",
day = "1",
language = "English (US)",
isbn = "9781620812686",
pages = "1--26",
booktitle = "Veterans",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Transfusion support for veteran patients

AU - Ryder, Alex

AU - Tormey, Christopher A.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - The transfusion of blood products is an important and often life-saving aspect of medical management for military veterans seeking care at Veterans Administration (VA) facilities. However, blood product infusion is a complex process that is associated with both infectious and non-infectious hazards. Thus, the aim of this chapter is to review transfusion therapy for veteran patients with a particular emphasis on those guidelines and risks most applicable to veteran populations. The authors will outline current, evidence-based approaches for transfusions of red blood cells, platelets, plasma, and cryoprecipitate and discuss how these relate to veteran groups. Moreover, the authors will share their practical experiences in transfusion management at a large, VA Healthcare System especially for areas of management (e.g. the use of factor concentrates for non-hemophilia patients) which currently lack discrete, evidence-based approaches. Finally, the authors will address the risks of transfusion with a focus on those aspects of transfusion hazards that have been well-studied and are particularly unique to veteran patients (e.g. RBC alloimmunization and delayed hemolytic transfusion reactions). Practical strategies to overcome these potential problems will also be reviewed.

AB - The transfusion of blood products is an important and often life-saving aspect of medical management for military veterans seeking care at Veterans Administration (VA) facilities. However, blood product infusion is a complex process that is associated with both infectious and non-infectious hazards. Thus, the aim of this chapter is to review transfusion therapy for veteran patients with a particular emphasis on those guidelines and risks most applicable to veteran populations. The authors will outline current, evidence-based approaches for transfusions of red blood cells, platelets, plasma, and cryoprecipitate and discuss how these relate to veteran groups. Moreover, the authors will share their practical experiences in transfusion management at a large, VA Healthcare System especially for areas of management (e.g. the use of factor concentrates for non-hemophilia patients) which currently lack discrete, evidence-based approaches. Finally, the authors will address the risks of transfusion with a focus on those aspects of transfusion hazards that have been well-studied and are particularly unique to veteran patients (e.g. RBC alloimmunization and delayed hemolytic transfusion reactions). Practical strategies to overcome these potential problems will also be reviewed.

UR - http://www.scopus.com/inward/record.url?scp=84896432518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896432518&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84896432518

SN - 9781620812686

SP - 1

EP - 26

BT - Veterans

PB - Nova Science Publishers, Inc.

ER -